July 16, 2020 FDA keeps the new devices coming The pandemic prompts only a slight drop in medtech approvals.
November 19, 2018 Neurostimulation sham scuppers Mainstay Mainstay Medical still hopes for US approval of its Reactiv8 device for chronic back pain despite trial failure.
